semaglutide and cardiovascular outcomes in obesity A trial emulation Nature Medicine shows that treatment with tirzepatide showed similar levels of benefit on in people at elevated cardiovascular risk with and diabetes. Link VisualAbstract: Semaglutide and Cardiovascular Outcomes

They work with the body to improve glucose balance, making them a smart choice for anyone looking to boost GLP-1 naturally

The trade-offs to weigh: compounded products lack the FDA finished-product approval, supply consistency depends on the pharmacy, and the boxed warning for thyroid C-cell tumors that applies to branded semaglutide and tirzepatide based on rodent studies applies to the compounded versions as well

Stay Engaged With Your Healthcare Team Your healthcare providers are your partners in making the journey work for you

This combination controls blood sugar, reduces appetite, and promotes weight loss

There is no consistent, effective therapy for NAION other than discontinuation of semaglutide

13 Repeatedly losing and gaining weight (known as weight cycling) is also an independent risk factor for gallstones